Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 1041.26 | 949.42 | 10 |
| OPM % | 35.66 | 30.75 | - |
| PBDT | 402.27 | 326.90 | 23 |
| PBT | 381.95 | 308.10 | 24 |
| NP | 295.62 | 229.88 | 29 |